Wednesday, July 8, 2026

Patent intelligence · US

US 11000409

Devices and methods for slurry generation

granted A61PA61P3/04
Status granted
Linked drugs 3
Pipeline programs 6
Years to expiry 15
Applicant portfolio 308
Patent details — US 11000409

Quick answer

US 11000409 (Devices and methods for slurry generation) is held by MIRAKI INNOVATION THINK TANK LLC. Status: granted. Granted May 11, 2021. Expires May 6, 2041 (15 years remaining) — relevant for patent-cliff and LOE planning.

Key facts

Grant date
Expiration
Claims
41
CPC classes
A61P, A61P3/04

More from MIRAKI INNOVATION THINK TANK LLC

Related pharmaceutical patents in our USPTO index.

  1. US 12421228

    Naphthyridine derivatives as PRC2 inhibitors

    Mirati Therapeutics, Inc. · Expires Sep 18, 2045

    granted
  2. US 12421253

    Tetrahydropyridopyrimidine pan-KRas inhibitors

    Mirati Therapeutics, Inc. · Expires Sep 18, 2045

    granted
  3. US 12414911

    Topical compositions and methods of use

    MIRACLE FRUIT OIL L.L.C. · Expires Sep 11, 2045

    granted
  4. US 12412764

    Substrate-accommodating container

    MIRAIAL CO., LTD. · Expires Sep 4, 2045

    granted
  5. US 12398154

    Azaquinazoline pan-KRas inhibitors

    Mirati Therapeutics, Inc. · Expires Aug 21, 2045

    granted
  6. US 12383503

    Adagrasib solid pharmaceutical compositions

    Mirati Therapeutics, Inc. · Expires Aug 7, 2045

    granted
  7. US 12377101

    Combination therapies

    Mirati Therapeutics, Inc. · Expires Jul 31, 2045

    granted
  8. US 12371435

    Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitors

    Mirati Therapeutics, Inc. · Expires Jul 24, 2045

    granted

Frequently asked questions

What is US patent 11000409?

US 11000409 (Devices and methods for slurry generation) is held by MIRAKI INNOVATION THINK TANK LLC. Status: granted. Granted May 11, 2021. Expires May 6, 2041 (15 years remaining) — relevant for patent-cliff and LOE planning.

Who owns US 11000409?

MIRAKI INNOVATION THINK TANK LLC is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 308 pharmaceutical patents for this assignee.

When does US 11000409 expire?

Our index shows an expiration date of May 6, 2041 (15 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.